200 experts to take part in oncology summit

The Excellence in Oncology Care Conference (EIOC 2025) will be held in Dubai from 31st October to 2nd November, bringing together a distinguished line-up of more than 200 international speakers and 30 specialised organisations.

The conference, to be held at the InterContinental Dubai Festival City, serves as a pivotal platform in the Middle East for sharing cutting-edge research and strengthening global collaboration to enhance cancer prevention, diagnosis, and treatment.

The conference will further highlight the pivotal contribution of oncology nurses in delivering patient-centered care, managing symptoms, and providing psychosocial support, while experts in palliative care will share best practices in holistic care, pain management, and end-of-life decision-making to ensure dignity and quality of life for patients and their families.

Moreover, the APMEA Molecular Tumor Board (MTB) will serve as a global collaborative platform where multidisciplinary experts discuss complex cancer cases, leveraging genomic insights and molecular diagnostics to guide optimal treatment decisions.

Recently, the 6th Annual Emirates Oncology Society (EOS) Conference organised in collaboration with the Emirates Medical Association and supported by the Ministry of Health and Prevention (MoHAP) brought together over 700 oncology specialists and researchers from 20 countries.

Recognised as one of the region’s leading medical and scientific platforms, the two-day discussions on the latest advances in cancer diagnosis and treatment, focused on opportunities to enhance international research and scientific collaboration in this critical field.

The conference featured more than 120 speakers and over 50 scientific sessions, covering all major types of cancer through dedicated tracks, in addition to specialised workshops.

A large-scale exhibition accompanied the event, showcasing the participation of leading global pharmaceutical companies.

Esteemed international experts were joined by prominent UAE and regional physicians, positioning the conference as a unique platform for knowledge exchange.

Discussions also tackled the challenges of treating metastatic breast cancer, including endocrine resistance and the role of CDK4/6 inhibitors, with contributions from leading experts.

WAM